scholarly journals Breast cancer-associated protein – a novel binding partner of Mason-Pfizer monkey virus protease

2014 ◽  
Vol 95 (6) ◽  
pp. 1383-1389 ◽  
Author(s):  
Michaela Rumlová ◽  
Ivana Křížová ◽  
Romana Hadravová ◽  
Michal Doležal ◽  
Karolína Strohalmová ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Potential Role ◽  
Protein A ◽  
Proteolytic Processing ◽  
Particle Release ◽  
Binding Partner ◽  
Rich Domain ◽  
Virion Incorporation ◽  
C Terminus

We identified breast cancer-associated protein (BCA3) as a novel binding partner of Mason-Pfizer monkey virus (MPMV) protease (PR). The interaction was confirmed by co-immunoprecipitation and immunocolocalization of MPMV PR and BCA3. Full-length but not C-terminally truncated BCA3 was incorporated into MPMV virions. We ruled out the potential role of the G-patch domain, a glycine-rich domain located at the C terminus of MPMV PR, in BCA3 interaction and virion incorporation. Expression of BCA3 did not affect MPMV particle release and proteolytic processing; however, it slightly increased MPMV infectivity.

scholarly journals Proteolytic Processing of the C Terminus of the α1CSubunit of L-type Calcium Channels and the Role of a Proline-rich Domain in Membrane Tethering of Proteolytic Fragments

2000 ◽  
Vol 275 (12) ◽  
pp. 8556-8563 ◽  
Author(s):  
Brian L. Gerhardstein ◽  
Tianyan Gao ◽  
Moritz Bünemann ◽  
Tipu S. Puri ◽  
Adam Adair ◽  
...  
Keyword(s):  
Calcium Channels ◽  
Proteolytic Processing ◽  
Rich Domain ◽  
C Terminus ◽  
Membrane Tethering

The potential role of ERβ isoforms in the clinical management of breast cancer

2008 ◽  
Vol 53 (4) ◽  
pp. 374-380 ◽  
Author(s):  
C A Green ◽  
M B Peter ◽  
V Speirs ◽  
A M Shaaban
Keyword(s):  
Breast Cancer ◽  
Clinical Management ◽  
Potential Role

scholarly journals CRISPR/Cas9-mediated mutation revealed cytoplasmic tail is dispensable for IZUMO1 function and male fertility

Reproduction ◽  
2016 ◽  
Vol 152 (6) ◽  
pp. 665-672 ◽  
Author(s):  
Samantha A M Young ◽  
Haruhiko Miyata ◽  
Yuhkoh Satouh ◽  
Masanaga Muto ◽  
Martin R Larsen ◽  
...  
Keyword(s):  
Amino Acid ◽  
Point Mutation ◽  
Male Fertility ◽  
Stop Codon ◽  
Premature Stop Codon ◽  
Cytoplasmic Tail ◽  
Binding Partner ◽  
C Terminus ◽  
Manipulation System

IZUMO1 is a protein found in the head of spermatozoa that has been identified as essential for sperm–egg fusion. Its binding partner in the egg has been discovered (JUNO); however, the roles of several domains within IZUMO1 remain unexplored. One such domain is the C-terminus, which undergoes major phosphorylation changes in the cytoplasmic portion of the protein during rat epididymal transit. However, the cytoplasmic tail of IZUMO1 in many species is highly variable, ranging from 55 to one amino acid. Therefore, to understand the role of the cytoplasmic tail of IZUMO1 in mouse, we utilised the gene manipulation system of CRISPR/Cas9 to generate a point mutation resulting in a premature stop codon, producing mice with truncated IZUMO1. Mice without the cytoplasmic tail of IZUMO1 showed normal fertility but decreased the amount of protein, indicating that whilst this region is important for the expression level of IZUMO1, it is dispensable for fertilisation in the mouse.

scholarly journals The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)

2022 ◽  
Vol 15 (1) ◽  
pp. 101247
Author(s):  
Jane Howard ◽  
Chia Yin Goh ◽  
Karolina Weiner Gorzel ◽  
Michaela Higgins ◽  
Amanda McCann
Keyword(s):  
Breast Cancer ◽  
Extracellular Vesicles ◽  
Triple Negative Breast Cancer ◽  
Potential Role ◽  
Triple Negative

Identification of non-invasive biomarkers for early detection of breast cancer: A Review

2021 ◽  
Vol 2 (1) ◽  
pp. 01-05
Author(s):  
Asima Tayyab
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Potential Role ◽  
Small Volume ◽  
Breast Cancer Diagnosis ◽  
Diagnostic Purpose ◽  
Diagnose Breast Cancer ◽  
Non Invasive ◽  
Early Stages

Despite decades of research, diagnostic tests with specificity and accuracy for early breast cancer are yet unavailable. Major problems associated with poor diagnosis are either due to incompetency of reported biomarkers or small volume of patients under study. Moreover, heterogeneity of the disease further complicates the struggle of identifying effective biomarkers. Therefore, to improve the survival rate, look for new, sensitive and specific biomarkers for early breast cancer diagnosis is need of hour. In this study, we have reviewed recently reported serum biomarkers and categorized them based on their biomolecular nature such as protein, ctDNA, epigenetics regulation and miRNA. Potential role of these available biomarkers in early diagnosis of breast cancer has also been discussed. Based on the facts obtained from literature review, it is revealed that using any individual biomolecule as a biomarker is not sufficient to diagnose breast cancer at early stages rather it is suggested that a panel of proteins or miRNAs would offer better sensitivity and specificity. Whereas, unavailability of a potential ctDNA and epigenetics regulation candidate for diagnostic purpose is and suggest the use of more sophisticated techniques to unwound these regulations in serum especially at early stages of breast cancer.

Sign in / Sign up

Export Citation Format

Share Document